2023. Immune microenvironment in high-grade serous ovarian carcinomas: association with molecular profiles and neoadjuvant therapy outcome. Voprosy onkologii. 69, 1 (Mar. 2023), 74–81. DOI:https://doi.org/10.37469/0507-3758-2023-69-1-74-81.